Cures Within Reach for Cancer
More than 200 generic drugs approved for non-cancer indications have shown promise for treating cancer. Repurposing these drugs represents a major opportunity to improve outcomes for cancer patients and reduce healthcare costs, but this potential is currently unrealized due to a lack of commercial interest. Cures Within Reach for Cancer is identifying the most promising opportunities, facilitating clinical testing and incorporation into standard of care, and creating sustainable funding models.
Connect with Cures Within Reach for Cancer